Concert Pharmaceuticals I... (CNCE)
NASDAQ: CNCE
· Real-Time Price · USD
8.37
0.00 (0.00%)
At close: Mar 03, 2023, 10:00 PM
Concert Pharmaceuticals Revenue
Concert Pharmaceuticals reported an annual revenue of $32.58M, reflecting a 312.28% growth. For the quarter ending September 30, 2022, Concert Pharmaceuticals generated $8K in revenue.
Revenue (ttm)
32.58M
Revenue Growth
312.28%
Price / Sales Ratio
3.33
Revenue / Employee
509.03K
Employees
64
Market Cap
0
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2021 | 32.58M | +312.28% |
| Dec 31, 2020 | 7.9M | +633.70% |
| Dec 31, 2019 | 1.08M | -89.75% |
| Dec 31, 2018 | 10.51M | -92.70% |
| Dec 31, 2017 | 143.89M | +82595.98% |
| Dec 31, 2016 | 174K | -99.74% |
| Dec 31, 2015 | 66.73M | +678.09% |
| Dec 31, 2014 | 8.58M | -66.25% |
| Dec 31, 2013 | 25.41M | +97.74% |
| Dec 31, 2012 | 12.85M | -34.00% |
| Dec 31, 2011 | 19.47M | n/a |